Open AccessParkinson’s Disease and Gene Therapy
Author(s) -
Mustafa M. Amin,
Aldy Safruddin Rambe,
Kiking Ritarwan
Publication year - 2021
Publication title -
open access macedonian journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.288
H-Index - 17
ISSN - 1857-9655
DOI - 10.3889/oamjms.2021.6321
Subject(s) - medicine , disease , parkinson's disease , genetic enhancement , dopamine , neuroscience , pathogenesis , bioinformatics , intensive care medicine , gene , pathology , genetics , biology
Since its introduction for more than a century, Parkinson’s disease has caught attention in the field of neuroscience. From the beginning of understanding its pathogenesis of dopamine pathways, many studies have grown in finding the treatment of the disease. In the beginning, medications showed promise results until each of them had its limitation in treating the disease. Another focus of attention from studies in the last decade was from gene therapy, and early phases of studies have shown some pledging moments for the disease.